Keck School of Medicine of USC

Keck School of Medicine of USC

We are dedicated to promoting health, preventing and curing disease, advancing biomedical research and educating tomorrow’s physicians and scientists.

 

PI3K/AKT/mTOR Inhibition in Advanced BC: Is There Any Benefit With Alpelisib, Capivasertib, and Everolimus?

62 views
February 9, 2021
0 Comments
Login to view comments. Click here to Login
8th Annual USC Multi-Disciplinary Breast Cancer Symposium